Weight-loss drug linked to lower eye-disease risk in patients with diabetes

The popular diabetes and weight-loss medication tirzepatide may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators.

607-255-6074mediarelations@cornell.edu

Tip Sheets

Expert Quotes

Featured Video

In this episode of Research Matters, economist Chris Barrett digs into why food prices remain so stubbornly high — from climate shocks and geopolitical conflict to supply chain bottlenecks and fragile global markets that amplify volatility. 

In The News

CBS News

John Tobin-de la Puente, professor of practice, advises businesses not to rely on the Trump administration's repeal of environmental regulations for long-term planning.

Marketplace

Andrew Novaković, Cornell University agricultural economics professor emeritus, discusses how school milk choices may impact lifelong milk consumption habits.

Grist

An analysis from researchers at Cornell University found that the data center build-out could add as much as 44 million metric tons of carbon dioxide to the atmosphere by 2030.

Wired

Cornell labor economist Erica Groshen says New York’s effort to track AI-related layoffs is a start, but argues employers should be required to share richer data on changing skills and occupations so workers can navigate transitions, rather than simply labeling job losses as caused by AI.

Associated Press

Jura Liaukonyte, a Cornell University marketing professor, explains why brands pay a premium for Super Bowl ads to reach a unified audience.

The Independent

Cornell University sociologist Cristobal Young discusses how the ultra-wealthy are unlikely to leave California in response to new taxes.